Top

BMC Oral Health

Published in:

Open Access 01-12-2021 | Research

Effects of platelet concentrates on implant stability and marginal bone loss: a systematic review and meta-analysis

Authors: Changxing Qu, Feng Luo, Guang Hong, Qianbing Wan

Published in: BMC Oral Health | Issue 1/2021

Abstract

Background

Osseointegration is essential for the success and stability of implants. Platelet concentrates were reported to enhance osseointegration and improve implant stability. The purpose of this review is to systematically analyze the effects of platelet concentrates on implant stability and marginal bone loss.

Methods

Two researchers independently performed searches in the following databases (last searched on 21 July 2021): MEDLINE (PubMed), Cochrane Library, EMBASE, and Web of Science. In addition, a manual search was carried out on references of relevant reviews and initially included studies. All randomized controlled trials (RCTs) and controlled clinical trials (CCTs) on the application of platelet concentrates in the implant surgery procedure were included. The risk of bias of RCTs and CCTs were assessed with a revised Cochrane risk of bias tool for randomized trials (RoB 2.0) and the risk of bias in non-randomized studies—of interventions (ROBINS-I) tool, respectively. Meta-analyses on implant stability and marginal bone loss were conducted. Researchers used mean difference or standardized mean difference as the effect size and calculated the 95% confidence interval. In addition, subgroup analysis was performed based on the following factors: type of platelet concentrates, method of application, and study design.

Results

Fourteen studies with 284 participants and 588 implants were included in the final analysis. 11 studies reported implant stability and 5 studies reported marginal bone level or marginal bone loss. 3 studies had high risk of bias. The meta-analysis results showed that platelet concentrates can significantly increase implant stability at 1 week (6 studies, 302 implants, MD 4.26, 95% CI 2.03–6.49, P < 0.001) and 4 weeks (8 studies, 373 implants, MD 0.67, 95% CI 0.46–0.88, P < 0.001) after insertion, significantly reduced marginal bone loss at 3 months after insertion (4 studies, 95 implants, mesial: MD − 0.33, 95% CI − 0.46 to − 0.20, P < 0.001; distal: MD − 0.38, 95% CI − 0.54 to − 0.22, P < 0.001). However, the improvement of implant stability at 12 weeks after insertion was limited (P = 0.10). Subgroup analysis showed that PRP did not significantly improve implant stability at 1 week and 4 weeks after insertion (P = 0.38, P = 0.17). Platelet concentrates only placed in the implant sites did not significantly improve implant stability at 1 week after insertion (P = 0.20).

Conclusions

Platelet concentrates can significantly improve implant stability and reduce marginal bone loss in the short term. Large-scale studies with long follow‐up periods are required to explore their long-term effects and compare effects of different types.

Trial registration

This study was registered on PROSPERO, with the Registration Number being CRD42021270214.

Available only for authorised users

Pirpir C, Yilmaz O, Candirli C, Balaban E. Evaluation of effectiveness of concentrated growth factor on osseointegration. Int J Implant Dent. 2017;3:7.PubMedPubMedCentralCrossRef

Sleem S, Zayet MK, El-Ghareeb TI, Saleh HAK. Evaluation of the bio-stimulatory effect of platelet rich fibrin augmented by diode LASER compared to platelet rich fibrin alone on dental implant replacing posterior mandibular teeth. Randomised clinical trial: split mouth study. Open Access Maced J Med Sci. 2019;7:869–75.PubMedPubMedCentralCrossRef

Brånemark PI. Osseointegration and its experimental background. J Prosthet Dent. 1983;50:399–410.PubMedCrossRef

Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants. 1986;1:11–25.PubMed

Smith DE, Zarb GA. Criteria for success of osseointegrated endosseous implants. J Prosthet Dent. 1989;62:567–72.PubMedCrossRef

Alhussaini AHA. Effect of platelet-rich fibrin and bone morphogenetic protein on dental implant stability. J Craniofac Surg. 2019;30:1492–6.PubMedCrossRef

Al-Hamed FS, Mahri M, Al-Waeli H, Torres J, Badran Z, Tamimi F. Regenerative effect of platelet concentrates in oral and craniofacial regeneration. Front Cardiovasc Med. 2019;6:126.PubMedPubMedCentralCrossRef

Kiran NK, Mukunda KS, Raj AT, Tilakt N. Platelet concentrates: a promising innovation in dentistry. 2011.

Agrawal AA. Evolution, current status and advances in application of platelet concentrate in periodontics and implantology. World J Clin Cases. 2017;5(5):159–71.PubMedPubMedCentralCrossRef

10.

Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002;18(1):27–33.PubMedCrossRef

11.

Feigin K, Shope B. Use of platelet-rich plasma and platelet-rich fibrin in dentistry and oral surgery: introduction and review of the literature. J Vet Dent. 2019;36(2):109–23.PubMedCrossRef

12.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e37–44.PubMedCrossRef

13.

Kim TH, Kim SH, Sándor GK, Kim YD. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol. 2014;59(5):550–8.PubMedCrossRef

14.

Miron RJ, Pinto NR, Quirynen M, Ghanaati S. Standardization of relative centrifugal forces in studies related to platelet-rich fibrin. J Periodontol. 2019;90(8):817–20.PubMedCrossRef

15.

Mirković S, Djurdjević-Mirković T, Pugkar T. Application of concentrated growth factors in reconstruction of bone defects after removal of large jaw cysts—the two cases report. Vojnosanit Pregl. 2015;72(4):368–71.PubMedCrossRef

16.

Koyuncu BO, Celik KI, Yuce MO, Gunbay T, Comlekoglu ME. The role of concentrated growth factor on implant stability: a preliminary study. J Stomatol Oral Maxillofac Surg. 2020;121:363–7.CrossRef

17.

Kundu R, Rathee M. Effect of platelet-rich-plasma (PRP) and implant surface topography on implant stability and bone. J Clin Diagn Res. 2014;8:Zc26–30.PubMedPubMedCentral

18.

Vijayalakshmi R, Rajmohan CS, Deepalakshmi D, Sivakami G. Use of platelet rich fibrin in a fenestration defect around an implant. J Indian Soc Periodontol. 2012;16:108–12.PubMedPubMedCentralCrossRef

19.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e51-55.PubMedCrossRef

20.

Georgakopoulos I, Tsantis S, Georgakopoulos P, Korfiatis P, Fanti E, Martelli M, Costaridou L, Petsas T, Panayiotakis G, Martelli FS. The impact of Platelet Rich Plasma (PRP) in osseointegration of oral implants in dental panoramic radiography: texture based evaluation. Clin Cases Miner Bone Metab. 2014;11:59–66.PubMedPubMedCentral

21.

Öncü E, Alaaddinoğlu EE. The effect of platelet-rich fibrin on implant stability. Int J Oral Maxillofac Implants. 2015;30:578–82.PubMedCrossRef

22.

Öncü E, Erbeyoğlu AA. Enhancement of immediate implant stability and recovery using platelet-rich fibrin. Int J Periodontics Restorative Dent. 2019;39:e58–63.PubMedCrossRef

23.

Tabrizi R, Arabion H, Karagah T. Does platelet-rich fibrin increase the stability of implants in the posterior of the maxilla? A split-mouth randomized clinical trial. Int J Oral Maxillofac Surg. 2018;47:672–5.PubMedCrossRef

24.

Torkzaban P, Khoshhal M, Ghamari A, Tapak L, Houshyar E. Efficacy of application of platelet-rich fibrin for improvement of implant stability: a clinical trial. J Long Term Eff Med Implants. 2018;28:259–66.PubMedCrossRef

25.

Boora P, Rathee M, Bhoria M. Effect of platelet rich fibrin (PRF) on peri-implant soft tissue and crestal bone in one-stage implant placement: a randomized controlled trial. J Clin Diagn Res. 2015;9:Zc18–21.PubMedPubMedCentral

26.

Fujioka-Kobayashi M, Miron RJ, Moraschini V, Zhang Y, Gruber R, Wang HL. Efficacy of platelet-rich fibrin on bone formation, part 2: guided bone regeneration, sinus elevation and implant therapy. Int J Oral Implantol (Berl). 2021;14(3):285–302.

27.

González-Serrano J, Vallina C, González-Serrano C, Sánchez-Monescillo A, Torres J, Hernández G, López-Pintor RM. Effect of platelet concentrates on marginal bone loss of immediate implant procedures: a systematic review and meta-analysis. Materials (Basel). 2021;14(16):4562.CrossRef

28.

Khan AS, Zaheer N, Zaigham AM, Shahbaz M, Zaheer U, Alam MK. Effect of platelet-rich plasma on bone healing in immediate implants analyzed by cone beam computerized tomography: a randomized controlled trial. Biomed Res Int. 2021;2021:6685991.PubMedPubMedCentralCrossRef

29.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.PubMedPubMedCentralCrossRef

30.

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.PubMedPubMedCentralCrossRef

31.

Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants. 2005;20(4):569–77.PubMed

32.

Sundar G, Sridharan S, Sundaram RR, Prabhu S, Rao R, Rudresh V. Impact of well-controlled type 2 diabetes mellitus on implant stability and bone biomarkers. Int J Oral Maxillofac Implants. 2019;34(6):1441–9.PubMedCrossRef

33.

Turkyilmaz I. One-year clinical outcome of dental implants placed in patients with type 2 diabetes mellitus: a case series. Implant Dent. 2010;19(4):323–9.PubMedCrossRef

34.

Del Fabbro M, Karanxha L, Panda S, Bucchi C, Nadathur Doraiswamy J, Sankari M, Ramamoorthi S, Varghese S, Taschieri S. Autologous platelet concentrates for treating periodontal infrabony defects. Cochrane Database Syst Rev. 2018;11(11):011423.

35.

Esposito M, Grusovin MG, Maghaireh H, Worthington HV. Interventions for replacing missing teeth: different times for loading dental implants. Cochrane Database Syst Rev. 2013;2013(3):003878.

36.

Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Expósito JA, Bolíbar I, Rodríguez L, Garcia J, Zaror C. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2016;2016(5):Cd006899.

37.

Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014;2014(4):Cd010071.PubMedCentral

38.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:14898.

39.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.PubMedPubMedCentralCrossRef

40.

Monov G, Fuerst G, Tepper G, Watzak G, Zechner W, Watzek G. The effect of platelet-rich plasma upon implant stability measured by resonance frequency analysis in the lower anterior mandibles—a pilot study. Clin Oral Implants Res. 2005;16:461–5.PubMedCrossRef

41.

Ergun G, Egilmez F, Cekic-Nagas S, Karaca IR, Bozkaya S. Effect of platelet-rich plasma on the outcome of early loaded dental implants: a 3-year follow-up study. J Oral Implantol. 2013;39:256–63.CrossRef

42.

Diana C, Mohanty S, Chaudhary Z, Kumari S, Dabas J, Bodh R. Does platelet-rich fibrin have a role in osseointegration of immediate implants? A randomized, single-blind, controlled clinical trial. Int J Oral Maxillofac Surg. 2018;47:1178–88.PubMedCrossRef

43.

Khan ZA, Jhingran R, Bains VK, Madan R, Srivastava R, Rizvi I. Evaluation of peri-implant tissues around nanopore surface implants with or without platelet rich fibrin: a clinico-radiographic study. Biomed Mater. 2018;13:025002.PubMedCrossRef

44.

McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55–61.PubMedCrossRef

45.

Strauss FJ, Stähli A, Gruber R. The use of platelet-rich fibrin to enhance the outcomes of implant therapy: a systematic review. Clin Oral Implants Res. 2018;29(Suppl 18):6–19.PubMedPubMedCentralCrossRef

46.

Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e56-60.PubMedCrossRef

47.

Simonpieri A, Del Corso M, Vervelle A, Jimbo R, Inchingolo F, Sammartino G, Dohan Ehrenfest DM. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol. 2012;13:1231–56.PubMedCrossRef

48.

Taschieri S, Lolato A, Ofer M, Testori T, Francetti L, Del Fabbro M. Immediate post-extraction implants with or without pure platelet-rich plasma: a 5-year follow-up study. Oral Maxillofac Surg. 2017;21:147–57.PubMedCrossRef

49.

He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:707–13.PubMedCrossRef

50.

Ortolani E, Guerriero M, Coli A, Di Giannuario A, Minniti G, Polimeni A. Effect of PDGF, IGF-1 and PRP on the implant osseointegration. An histological and immunohistochemical study in rabbits. Ann Stomatol (Roma). 2014;5:66–8.

51.

Chang PC, Seol YJ, Cirelli JA, Pellegrini G, Jin Q, Franco LM, Goldstein SA, Chandler LA, Sosnowski B, Giannobile WV. PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration. Gene Ther. 2010;17:95–104.PubMedCrossRef

52.

Qin J, Wang L, Zheng L, Zhou X, Zhang Y, Yang T, Zhou Y. Concentrated growth factor promotes Schwann cell migration partly through the integrin β1-mediated activation of the focal adhesion kinase pathway. Int J Mol Med. 2016;37(5):1363–70.PubMedCrossRef

53.

Lee HM, Shen EC, Shen JT, Fu E, Chiu HC, Hsia YJ. Tensile strength, growth factor content and proliferation activities for two platelet concentrates of platelet-rich fibrin and concentrated growth factor. J Dent Sci. 2020;15:141–6.PubMedPubMedCentralCrossRef

54.

Wei Z, Liu S, Chen Z, Huang X. Comparison of the effect on proliferation of osteoblasts MC3T3-E1 between the concentrated growth factor extract and the platelet-rich fibrin extract. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45:901–8.PubMed

55.

Attia S, Narberhaus C, Schaaf H, Streckbein P, Pons-Kühnemann J, Schmitt C, Neukam FW, Howaldt HP, Böttger S. Long-term influence of platelet-rich plasma (PRP) on dental implants after maxillary augmentation: implant survival and success rates. J Clin Med. 2020;9(2):391.PubMedCentralCrossRef

56.

Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D, Chen L. Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defects. J Periodontol. 2020;91(4):462–72.PubMedCrossRef

57.

Jaffin RA, Berman CL. The excessive loss of Branemark fixtures in type IV bone: a 5-year analysis. J Periodontol. 1991;62:2–4.PubMedCrossRef

58.

Muelas-Jiménez MI, Olmedo-Gaya MV, Manzano-Moreno FJ, Reyes-Botella C, Vallecillo-Capilla M. Long-term survival of dental implants with different prosthetic loading times in healthy patients: a 5-year retrospective clinical study. J Prosthodont. 2017;26:99–106.PubMedCrossRef

59.

Sennerby L, Meredith N. Implant stability measurements using resonance frequency analysis: biological and biomechanical aspects and clinical implications. Periodontol. 2000;2008(47):51–66.

60.

Raheja A, Mehta V. Platelet rich plasma—a breakthrough in implant dentistry: a review article.

61.

Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J. Optimized platelet-rich fibrin with the low-speed concept: growth factor release, biocompatibility, and cellular response. J Periodontol. 2017;88:112–21.PubMedCrossRef

62.

Ibraheem EM, Eldeen AM. Impact of platelet-rich plasma on bone height changes around platform switched implants supporting mandibular overdentures in controlled diabetic patients. Open Access Maced J Med Sci. 2015;3(4):722–6.PubMedPubMedCentralCrossRef

63.

Malik A, Shaari R, Rahman SA, Aljuboori MJ. Influence of platelet-rich plasma on dental implants, Osseointegration in well-controlled diabetic patients. Dent Implantol Update. 2012;23(12):89–96.PubMed

64.

Ustaoğlu G, Paksoy T, Gümüş K. Titanium-prepared platelet-rich fibrin versus connective tissue graft on peri-implant soft tissue thickening and keratinized mucosa width: a randomized. Controlled Trial J Oral Maxillofac Surg. 2020;78(7):1112–23.PubMedCrossRef

65.

Temmerman A, Cleeren GJ, Castro AB, Teughels W, Quirynen M. L-PRF for increasing the width of keratinized mucosa around implants: a split-mouth, randomized, controlled pilot clinical trial. J Periodontal Res. 2018;53(5):793–800.PubMedCrossRef

66.

Gkikas G, McLaughlin M, Renvert S, Polyzois I. A prospective study comparing the effect of l-prf and porous titanium granules on the preservation of the buccal bone plate following immediate implant placement. Int J Periodontics Restorative Dent. 2020;40(5):767–74.PubMedCrossRef

67.

Arakeeb MAA, Zaky AA, Harhash TA, Salem WS, El-Mofty M. Effect of combined application of growth factors and diode laser bio-stimulation on the osseo integration of dental implants. Open Access Maced J Med Sci. 2019;7(15):2520–7.PubMedPubMedCentralCrossRef

68.

Pal US, Daga D, Singh RK, Kumar L, Singh M. Comparison of stability with two-time use of platelet-rich growth factor versus one-time use of platelet-rich growth factor in immediate placement of dental implant in infected socket. Natl J Maxillofac Surg. 2018;9(2):209–14.PubMedPubMedCentralCrossRef

Title: Effects of platelet concentrates on implant stability and marginal bone loss: a systematic review and meta-analysis
Authors: Changxing Qu
Feng Luo
Guang Hong
Qianbing Wan
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Oral Health / Issue 1/2021
Electronic ISSN: 1472-6831
DOI: https://doi.org/10.1186/s12903-021-01929-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effects of platelet concentrates on implant stability and marginal bone loss: a systematic review and meta-analysis

Abstract

Background

Methods

Results

Conclusions

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

In vitro comparison of cleaning efficacy and force of cylindric interdental brush versus an interdental rubber pick

Effect of photobiomodulation in secondary intention gingival wound healing—a systematic review and meta-analysis

Oral health status of 12-year-old children in Lisu minority ethnic group in China: a cross-sectional study

Nasopalatine duct cyst with sebaceous differentiation: a rare case report with literature review

The relationship between different types of caries and periodontal disease severity in middle-aged and elderly people: findings from the 4th National Oral Health Survey of China

High pretreatment systemic immune-inflammation index values are associated with diminished short-term success after temporomandibular joint arthrocentesis procedure